Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Chongqing Paijin Biotechnology Co Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
Latest Hotspot
9 min read
Chongqing Paijin Biotechnology Co Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Chongqing Paijin Biotechnology Co Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach
Read →
Chongqing Hilan Pharmaceutical Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
Latest Hotspot
9 min read
Chongqing Hilan Pharmaceutical Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Chongqing Hilan Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outrea
Read →
Chongqing Chenan Biopharmaceutical Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
Latest Hotspot
9 min read
Chongqing Chenan Biopharmaceutical Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Chongqing Chenan Biopharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and ou
Read →
China Resources Double-Crane Pharmaceutical Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
Latest Hotspot
9 min read
China Resources Double-Crane Pharmaceutical Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for China Resources Double-Crane Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signa
Read →
CHIESI Farmaceutici SpA Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
Latest Hotspot
8 min read
CHIESI Farmaceutici SpA Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for CHIESI Farmaceutici SpA: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.
Read →
Chengdu Zenitar Biomedical Technology Co., Ltd Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
Latest Hotspot
9 min read
Chengdu Zenitar Biomedical Technology Co., Ltd Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Chengdu Zenitar Biomedical Technology Co., Ltd: pipeline stage, evidence package, IP risk, deal precedent, financial signals and
Read →
Chengdu Shibeikang Biopharmaceutical Technology Co., Ltd., Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
Latest Hotspot
9 min read
Chengdu Shibeikang Biopharmaceutical Technology Co., Ltd., Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Chengdu Shibeikang Biopharmaceutical Technology Co., Ltd.,: pipeline stage, evidence package, IP risk, deal precedent, financial
Read →
Chengdu Shengnuo Biotechnology Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
Latest Hotspot
9 min read
Chengdu Shengnuo Biotechnology Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Chengdu Shengnuo Biotechnology Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outrea
Read →
Chengdu SciMount Pharmatech Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
Latest Hotspot
8 min read
Chengdu SciMount Pharmatech Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Chengdu SciMount Pharmatech Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach
Read →
Chengdu Keen Biological Technology Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
Latest Hotspot
9 min read
Chengdu Keen Biological Technology Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Chengdu Keen Biological Technology Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and ou
Read →
Chengdu Di'ao Pharmaceutical Group Co. Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
Latest Hotspot
9 min read
Chengdu Di'ao Pharmaceutical Group Co. Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Chengdu Di'ao Pharmaceutical Group Co. Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and out
Read →
Charité - Universitätsmedizin Berlin Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
Latest Hotspot
9 min read
Charité - Universitätsmedizin Berlin Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Charité - Universitätsmedizin Berlin: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach r
Read →